Breast Cancer Clinical Trial

The Women In Steady Exercise Research (WISER) Survivor Trial

Summary

WISER Survivor is a one year weight loss and exercise study for sedentary breast cancer survivors who are overweight or obese with breast cancer related lymphedema. There will be four groups in this trial: exercise only, weight loss only, exercise and weight-loss combined, and a control group. The primary purpose of this study is to test the effects of these interventions on clinical lymphedema outcomes. Secondary outcomes include weight loss, breast cancer related biomarkers, and quality of life. To the extent that funding will be available, participants will be followed long term to examine effects on recurrence and mortality.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

breast cancer survivor
overweight or obese (BMI of 25 or greater)
must have breast cancer related lymphedema
at least 6 months post-treatment (e.g. surgery, chemotherapy, or radiotherapy) but there will be no upper limit on time elapsed from diagnosis
the eligible age range will have no lower limit.
currently free of cancer

Exclusion Criteria:

medical conditions or medications that would prohibit participation in an exercise program or would negatively impact our ability to test our primary aims
inability to walk for 6 minutes unaided
extremely obese (body mass index greater or equal to 50 kg/m2)
plans for additional (e.g. curative or reconstructive) surgery during the study period
self-report of weight-lifting within the past year
already engaging in 3 or more times weekly aerobic activity of moderate intensity
planning to move away from the area over the next year
current use of weight loss medication (OTC or prescription)
self-report of alcohol or substance abuse within the past 12 months, including at-risk drinking (current consumption of more than 14 alcoholic drinks per week)
weight loss of greater than 10 % in the past 3 months
history of bariatric surgery
women who are pregnant

Study is for people with:

Breast Cancer

Estimated Enrollment:

450

Study ID:

NCT01515124

Recruitment Status:

Completed

Sponsor:

Milton S. Hershey Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The Penn TREC Survivorship Center
Hershey Pennsylvania, 17033, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

450

Study ID:

NCT01515124

Recruitment Status:

Completed

Sponsor:


Milton S. Hershey Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider